223 related articles for article (PubMed ID: 10184835)
1. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
Boyer P; Danion JM; Bisserbe JC; Hotton JM; Troy S
Pharmacoeconomics; 1998 Jan; 13(1 Pt 2):157-69. PubMed ID: 10184835
[TBL] [Abstract][Full Text] [Related]
2. Sertraline. A pharmacoeconomic evaluation of its use in depression.
Davis R; Wilde MI
Pharmacoeconomics; 1996 Oct; 10(4):409-31. PubMed ID: 10184609
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
Aguglia E; Casacchia M; Cassano GB; Faravelli C; Ferrari G; Giordano P; Pancheri P; Ravizza L; Trabucchi M; Bolino F
Int Clin Psychopharmacol; 1993; 8(3):197-202. PubMed ID: 8263318
[TBL] [Abstract][Full Text] [Related]
4. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
Bennie EH; Mullin JM; Martindale JJ
J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
[TBL] [Abstract][Full Text] [Related]
5. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
Russell JM; Berndt ER; Miceli R; Colucci S; Grudzinski AN
Am J Manag Care; 1999 May; 5(5):597-606. PubMed ID: 10537866
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.
Sclar DA; Robison LM; Skaer TL; Galin RS; Legg RF; Nemec NL; Hughes TE; Buesching DP; Morgan M
J Int Med Res; 1995; 23(6):395-412. PubMed ID: 8746607
[TBL] [Abstract][Full Text] [Related]
7. Quality of life: experience with sertraline.
Turner R
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():27-31. PubMed ID: 7963448
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
9. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.
Ekselius L; von Knorring L; Eberhard G
Int Clin Psychopharmacol; 1997 Nov; 12(6):323-31. PubMed ID: 9547134
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
Hylan TR; Crown WH; Meneades L; Heiligenstein JH; Melfi CA; Croghan TW; Buesching DP
J Affect Disord; 1998 Jan; 47(1-3):71-9. PubMed ID: 9476746
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
Thase ME; Blomgren SL; Birkett MA; Apter JT; Tepner RG
J Clin Psychiatry; 1997 Jan; 58(1):16-21. PubMed ID: 9055832
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
Lydiard RB; Stahl SM; Hertzman M; Harrison WM
J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
[TBL] [Abstract][Full Text] [Related]
14. Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans.
Polsky D; Onesirosan P; Bauer MS; Glick HA
J Clin Psychiatry; 2002 Feb; 63(2):156-64. PubMed ID: 11874218
[TBL] [Abstract][Full Text] [Related]
15. Sertraline for premenstrual dysphoric disorder.
Cohen LS
JAMA; 1998 Feb; 279(5):357-8. PubMed ID: 9459467
[No Abstract] [Full Text] [Related]
16. Therapeutic interchange of fluoxetine and sertraline: experience in the clinical setting.
Stock AJ; Kofoed L
Am J Hosp Pharm; 1994 Sep; 51(18):2279-81. PubMed ID: 7801990
[No Abstract] [Full Text] [Related]
17. Long-term costs of treatment for depression: impact of drug selection and guideline adherence.
Crown WH; Treglia M; Meneades L; White A
Value Health; 2001; 4(4):295-307. PubMed ID: 11705297
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.
Serrano-Blanco A; Gabarron E; Garcia-Bayo I; Soler-Vila M; Caramés E; Peñarrubia-Maria MT; Pinto-Meza A; Haro JM;
J Affect Disord; 2006 Apr; 91(2-3):153-63. PubMed ID: 16458976
[TBL] [Abstract][Full Text] [Related]
19. Are patients who are intolerant to one SSRI intolerant to another?
Brown WA; Harrison W
Psychopharmacol Bull; 1992; 28(3):253-6. PubMed ID: 1480728
[TBL] [Abstract][Full Text] [Related]
20. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
Zarate CA; Kando JC; Tohen M; Weiss MK; Cole JO
J Clin Psychiatry; 1996 Feb; 57(2):67-71. PubMed ID: 8591971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
